NASDAQ · Medical - Diagnostics & Research

GRAIL, Inc. (GRAL) Stock

$140.58 +6.01% NASDAQ: GRAL Healthcare

Valuation

MetricValue
Price$140.58
Market Cap$6.03B
P/E Ratio-14.69
P/B Ratio2.43
P/S Ratio37.20
EPS (TTM)$-11.11
52-Week High$163.77
52-Week Low$41.50
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-15.88%
ROA-13.77%
ROCE-20.26%
Gross Margin-363.27%
Operating Margin-363.27%
Net Margin-236.95%
Debt/Equity0.04
Current Ratio11.93

Annual Financials (USD)

Metric20212022202320242025
Revenue$15.0M$56.0M$93.0M$126.0M$147.0M
Operating Profit$-1.3B$-5.4B$-1.5B$-2.2B$-534.0M
Net Profit$-1.2B$-5.4B$-1.5B$-2.0B$-408.0M
EPS$-40.18$-173.87$-47.20$-63.54$-11.11
Op Margin-8659.6%-9798.2%-1627.6%-1743.0%-362.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$9.7B$5.6B$4.6B$3.0B$2.9B
Total Liabilities$307.0M$956.0M$911.0M$480.0M$344.0M
Cash$221.0M$242.0M$97.0M$214.0M$250.0M
Borrowings$111.0M$96.0M$84.0M$68.0M$98.0M

Latest News

Priority Health Collaborates With GRAIL as the First Michigan Health Plan to Offer the Galleri® Multi-Cancer Early Detection Blood Test to Employer Plans PR Newswire · Jul 16, 2026 Jeff Bezos Backed Grail Before It Lost Half Its Value. Here's Whether He Was Early -- or Just Wrong. Motley Fool · Jul 13, 2026 Prediction: Grail Stock Will Skyrocket to $100 in 1 Year Motley Fool · Jul 2, 2026 GRAIL Completes $110 Million Equity Financing With Samsung Entities PR Newswire · Jun 25, 2026 A Blood Test That Screens for 50+ Cancers Just Moved Closer to Real-World Use. Here's What It Means for Grail Investors. Motley Fool · Jun 21, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-688.0M$-561.0M$-596.0M$-577.0M$-299.0M
Investing Cash Flow$275.0M$-46.0M$-26.0M$-556.0M$-86.0M
Financing Cash Flow$389.0M$605.0M$464.0M$1.2B$0
Net Cash Flow$-143.0M$20.0M$-145.0M$116.0M$39.0M
Free Cash Flow$-758.0M$-584.0M$-609.0M$-582.0M$-299.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.47
EV / EBITDA-14.98
FCF Yield-4.80%
Quick Ratio10.74
Interest Coverage0.00
Return 1Y145.32%
Return 3Y—
Return 5Y—

Ownership

Insiders Held5.23%
Institutions Held83.49%
Institutions Float Held88.09%
Institutional HolderSharesReport Date
Baker Bros. Advisors, LP4,028,6142026-03-31
Farallon Capital Management LLC3,253,6842026-03-31
Blackrock Inc.2,968,5362026-03-31
State Street Corporation1,891,8932026-03-31
Primecap Management Company1,843,7722026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BLLNBillionToOne, Inc. $97.99 +2.70% 154.24 $4.51B 0.00%
BNRBurning Rock Biotech Limited $11.30 -3.42% -1.36 $11.94M 0.00%
CSTLCastle Biosciences, Inc. $34.35 +1.89% -53.92 $1.05B 0.00%
FLGTFulgent Genetics, Inc. $21.66 +4.05% -7.62 $615.26M 0.00%
GHGuardant Health, Inc. $167.43 +1.13% -48.23 $22.47B 0.00%

About GRAIL, Inc.

GRAIL, Inc. (GRAL) stock trades at $140.58 with a market capitalization of $6.03B. The stock is valued at a price-to-earnings (P/E) ratio of -14.69, price-to-book of 2.43, price-to-sales of 37.20. Over the past 52 weeks the stock has ranged between $41.50 and $163.77, and currently trades 14.2% below its 52-week high.

On profitability, GRAIL, Inc. generates a return on equity (ROE) of -15.88%, return on capital employed of -20.26%, an operating margin of -363.27%, a net profit margin of -236.95%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.31 +0.33% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.67 +1.27%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides